Protein C News and Research

RSS

Antibodies to SARS-CoV-2 and infection risk in healthcare workers following mRNA vaccination

A new study aimed to understand the risk of COVID-19 infection given certain serological parameters, in a group of vaccinated healthcare workers with high rates of exposure to the virus, followed up at 9 months from vaccination.

20 Jan 2022

Study finds Omicron infection effectively induces immunity against itself and enhances protection against other variants in vaccinated individuals

Researchers investigated the effectiveness of the SARS-CoV-2 Omicron-variant induced immunity, whether it is cross-protective against other variants, and if earlier infection with the SARS-CoV-2 Delta variant offers protection against Omicron.

20 Jan 2022

Recombinant bat coronavirus reported in wide-ranging Cambodian bat

A new study reports on the detection of recombinant coronaviruses in several bat species in Cambodia and of a related species in China.

20 Jan 2022

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

In a new study, researchers discuss the role of calcium signaling pathways as targets of inhibition in potential new antiviral therapeutic pathways for SARS-CoV-2.

20 Jan 2022

The association between green tea consumption and SARS-CoV-2 infection among Japanese

A study recently examined the association between consumption of green tea and SARS-CoV-2 infection in the Japanese population.

20 Jan 2022

The effect of different environmental conditions on the binding behavior of the S protein and RBD of SARS-CoV-2

Researchers investigated the binding behavior of spike protein and receptor-binding domain of SARS-CoV-2 under different environmental conditions.

20 Jan 2022

Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

Eikonoklastes Therapeutics, a preclinical stage biopharmaceutical company, today announced it has completed a license with the University of California San Diego to add a novel gene therapy for the treatment of neurodegenerative diseases.

20 Jan 2022

A novel assay for the rapid detection of SARS-CoV-2 variants

A new study discusses a new assay method designed by researchers to identify SARS-CoV-2 variants.

20 Jan 2022

Newly developed gene therapy can treat a severe form of epilepsy and prolong survival

Research from the University of Virginia School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.

20 Jan 2022

Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

Researchers investigate the cross-reactivity of the SARS-CoV-2 with pre-pandemic malaria-exposed sera samples collected from Cambodia.

19 Jan 2022

Variants of SARS-CoV-2 and preventive strategies

A recent review article published in the journal Advanced Science reviewed the features of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants. Using a physical and materials science perspective, the review also summarizes the most significant variants of SARS-CoV-2 encountered to date as well as possible preventive strategies.

19 Jan 2022

New findings could contribute to future therapeutics for muscle degeneration

An international team led by uOttawa Faculty of Medicine researchers have published findings that could contribute to future therapeutics for muscle degeneration due to old age, and diseases such as cancer and muscular dystrophy.

19 Jan 2022

Investigational cancer drug mimics the metabolic and therapeutic effects of fasting, mice study shows

An investigational cancer drug that starves tumors of their energy supply also shows evidence of improving whole body metabolism, according to a new study in mice from Washington University School of Medicine in St. Louis.

19 Jan 2022

Treatment with immune-boosting protein and radiation improves survival in mice with glioblastoma

Glioblastoma, an aggressive cancer in the brain or spinal cord, has proven stubbornly resistant to newer immunotherapies. And radiation and chemotherapy, the standard treatment for glioblastoma, result in fewer than 10% of patients surviving longer than five years after diagnosis.

19 Jan 2022

Exploring the interactions between multiple respiratory viruses

A recent report explores the dynamics of viral interference between various respiratory viruses in light of the ongoing COVID-19 pandemic.

19 Jan 2022

New mathematical model can calculate the risk of resistance evolution for drug pairs

Bacteria have dangerously evolved to thwart many of the medicines that were designed to kill them. As a result, a growing antibiotic resistance crisis is responsible for more than 700,000 deaths each year, emerging as one of the world's most pressing health issues.

19 Jan 2022

‘Decoy’ protein mitigates lung damage, death induced by aggressive SARS-CoV-2 variants

A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease, according to a Nature Chemical Biology study from researchers at the University of Illinois Chicago.

19 Jan 2022

Protein C News and Research

Antibodies to SARS-CoV-2 and infection risk in healthcare workers following mRNA vaccination

Study finds Omicron infection effectively induces immunity against itself and enhances protection against other variants in vaccinated individuals

Recombinant bat coronavirus reported in wide-ranging Cambodian bat

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

The association between green tea consumption and SARS-CoV-2 infection among Japanese

The effect of different environmental conditions on the binding behavior of the S protein and RBD of SARS-CoV-2

Eikonoklastes completes a license to add novel gene therapy for treating neurodegenerative diseases

A novel assay for the rapid detection of SARS-CoV-2 variants

Newly developed gene therapy can treat a severe form of epilepsy and prolong survival

Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

Variants of SARS-CoV-2 and preventive strategies

New findings could contribute to future therapeutics for muscle degeneration

Investigational cancer drug mimics the metabolic and therapeutic effects of fasting, mice study shows

Treatment with immune-boosting protein and radiation improves survival in mice with glioblastoma

Exploring the interactions between multiple respiratory viruses

New mathematical model can calculate the risk of resistance evolution for drug pairs

‘Decoy’ protein mitigates lung damage, death induced by aggressive SARS-CoV-2 variants

New structure prediction method allows scientists to map thousands of secreted proteins

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

Yale research sheds light on the lifespan and myriad functions of messenger RNAs

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News